Initially, the authors provided evidence that MEF cells derived from knockin mouse models expressing Parkinson's-associated R1441G or G2019S LRRK2 mutants exhibit increased levels of retarded (phosphorylated) Rab10 compared with control mice when analysed using Phos-tag gels with appropriate small-molecule controls. This evidence concerns the gene LRRK2 and Parkinson disease.